Fubotv earnings beat by $0.10, revenue topped estimates
Serina Therapeutics, Inc. (SER) Chief Scientific Officer Randall Moreadith reported selling 6,500 shares of common stock on July 7, 2025. The shares were sold at prices ranging from $5.55 to $5.94, totaling $36,855. The sale comes amid a challenging period for SER, with the stock down 14% in the past week and trading 54% below its 52-week high of $11.56.
On the same day, Moreadith exercised options to acquire 6,500 shares of Serina Therapeutics common stock at a price of $0.06 per share, for a total value of $390. Following these transactions, Moreadith directly owns 0 shares of Serina Therapeutics. According to InvestingPro data, the company faces significant challenges with negative EBITDA of -$18.92M and is expected to remain unprofitable this year. The company’s next earnings report is scheduled for August 7, 2025, where investors will be watching for signs of improvement in its financial health.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.